{"id":"https://openalex.org/W2490909896","doi":"https://doi.org/10.1016/b978-0-12-415787-3.00013-8","title":"Pharmacovigilance and Risk Management","display_name":"Pharmacovigilance and Risk Management","alternate_titles":[],"publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2490909896","doi":"https://doi.org/10.1016/b978-0-12-415787-3.00013-8","mag":"2490909896"},"language":"en","primary_location":{"id":"doi:10.1016/b978-0-12-415787-3.00013-8","doi":"https://doi.org/10.1016/b978-0-12-415787-3.00013-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-0-12-415787-3.00013-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463230","display_name":"Elsevier eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Global Clinical Trials Playbook","raw_type":"book-chapter"},"parent_works":[{"id":"https://openalex.org/W4210597141","display_name":"Global Clinical Trials Playbook","relationship":"volume"}],"lineage":["https://openalex.org/W2490909896","https://openalex.org/W4210597141"],"child_works_count":0,"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103173678","display_name":"Suzanne Gagnon","orcid":"https://orcid.org/0009-0007-3607-5425","observed_orcids":["https://orcid.org/0009-0007-3607-5425"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Suzanne Gagnon","raw_affiliation_strings":["ICON Clinical Research, North Wales, Pennsylvania, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICON Clinical Research, North Wales, Pennsylvania, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114031215","display_name":"Peter Schueler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Schueler","raw_affiliation_strings":["ICON Clinical Research, Langen, Hessen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICON Clinical Research, Langen, Hessen, Germany","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102778530","display_name":"James Fan","orcid":"https://orcid.org/0000-0003-3076-5664","observed_orcids":["https://orcid.org/0000-0003-3076-5664"]},"institutions":[{"id":"https://openalex.org/I4405266959","display_name":"ICON PLC (Ireland)","ror":"https://ror.org/00gmhs392","country_code":"IE","type":"company","lineage":["https://openalex.org/I4405266959"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"James (Dachao) Fan","raw_affiliation_strings":["ICON Clinical Research Pte Ltd/Asia Pacific, Singapore"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ICON Clinical Research Pte Ltd/Asia Pacific, Singapore","institution_ids":["https://openalex.org/I4405266959"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.095,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.83901515,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":null,"issue":null,"first_page":"141","last_page":"159"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9929999709129333},{"id":"https://openalex.org/keywords/risk-management","display_name":"risk management","score":0.8849999904632568},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9089999794960022},{"id":"https://openalex.org/keywords/safety-monitoring","display_name":"safety monitoring","score":0.6340000033378601},{"id":"https://openalex.org/keywords/clinical-trials","display_name":"clinical trials","score":0.6779999732971191},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.7409999966621399},{"id":"https://openalex.org/keywords/data-and-safety-monitoring-board","display_name":"data safety monitoring board","score":0.8309999704360962},{"id":"https://openalex.org/keywords/outsourcing","display_name":"outsourcing","score":0.7120000123977661},{"id":"https://openalex.org/keywords/quality-management-systems","display_name":"quality management systems","score":0.9350000023841858},{"id":"https://openalex.org/keywords/standard-operating-procedures","display_name":"standard operating procedures","score":0.8709999918937683},{"id":"https://openalex.org/keywords/risk-analysis","display_name":"risk analysis","score":0.6740000247955322},{"id":"https://openalex.org/keywords/risk-management-plan","display_name":"risk management plan","score":0.42500001192092896},{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.6460000276565552},{"id":"https://openalex.org/keywords/database-support","display_name":"database support","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.8941359519958496},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49864697456359863},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3333660960197449},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.13102459907531738}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/b978-0-12-415787-3.00013-8","doi":"https://doi.org/10.1016/b978-0-12-415787-3.00013-8","is_oa":false,"landing_page_url":"https://doi.org/10.1016/b978-0-12-415787-3.00013-8","pdf_url":null,"source":{"id":"https://openalex.org/S4306463230","display_name":"Elsevier eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Global Clinical Trials Playbook","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W7010386287"],"related_works":["https://openalex.org/W7170215955","https://openalex.org/W2122779529","https://openalex.org/W3205239327","https://openalex.org/W4403204611","https://openalex.org/W6967889894","https://openalex.org/W3196731983","https://openalex.org/W4409460255","https://openalex.org/W2142205302","https://openalex.org/W7165686802","https://openalex.org/W7162468921"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2490909896","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-08-23T00:00:00"}
